2993-3935

Gut Microbes Reports

Informa UK (Taylor & Francis)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 95 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact95 DOIs
2

Attach ORCID iDs across 13 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact13 DOIs
3

Deposit reference lists for 2 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 95 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 <i>Faecalibacterium longum</i> alleviate… (10.1080/29933935.2025.2459599)
Abstract ORCID
38.91 5
2 Scoring Microbiota Function: A Proposal to Use Features of E… (10.1080/29933935.2024.2376543)
Abstract ORCID
34.95 4
3 Quantitative Distribution Profile of Cadmium and Lead in Dif… (10.1080/29933935.2024.2313299)
Abstract ORCID
30.10 3
4 Precision nutrition through diet-gut microbiome interactions… (10.1080/29933935.2026.2650247)
Abstract ORCID
30.10 3
5 Emerging implications of bacterial biofilm in cancer biology… (10.1080/29933935.2024.2339270)
Abstract
26.98 11
6 Bimodal distribution of intestinal <i>Ca… (10.1080/29933935.2024.2358324)
Abstract
23.86 8
7 The Effects of Ceftriaxone on Glutamate Transporter Expressi… (10.1080/29933935.2024.2393727)
Abstract ORCID
23.86 2
8 Aurora Kinase A: Integrating Insights into Cancer, Inflammat… (10.1080/29933935.2024.2419069)
Abstract
23.86 8
9 Strengths and limitations of <i>in vitro… (10.1080/29933935.2026.2636336)
Abstract ORCID
23.86 2
10 Synbiotic combination of <i>Bifidobacter… (10.1080/29933935.2025.2490092)
Abstract
21.13 6
11 Two-week supplementation of <i>Bifidobac… (10.1080/29933935.2025.2508199)
Abstract
21.13 6
12 Obesity-associated gut microbiome influences diet-induced me… (10.1080/29933935.2025.2605879)
Abstract
19.45 5
13 The Paraguayan gut microbiome contains high abundance of the… (10.1080/29933935.2024.2332988)
Abstract
17.47 4
14 In silico metabolic modelling links microbiome-derived metab… (10.1080/29933935.2024.2443171)
Abstract
17.47 4
15 Bridging Microbiomes: Exploring Oral and Gut Microbiomes in… (10.1080/29933935.2025.2452471)
Abstract
17.47 4
16 Delivery Mode Impacts Gut Bacteriophage Colonization During… (10.1080/29933935.2025.2464631)
Abstract
17.47 4
17 Toxic metals impact gut microbiota and metabolic risk in fiv… (10.1080/29933935.2025.2481442)
Abstract
17.47 4
18 Gut Microbes Reports – highlighting the value in team and tr… (10.1080/29933935.2023.2270377)
Abstract ORCID
15.05 1
19 Looking at the full picture, using topic modeling to observe… (10.1080/29933935.2024.2378067)
Abstract
15.05 3
20 Comparison between two divergent diets, Mediterranean and We… (10.1080/29933935.2024.2439490)
Abstract
15.05 3
21 Role of phase-variable Mfa1 fimbriae of… (10.1080/29933935.2025.2468456)
Abstract ORCID
15.05 1
22 Common microbial signatures in blood and their amplification… (10.1080/29933935.2025.2473450)
Abstract
15.05 3
23 Addressing the global challenge of <i>He… (10.1080/29933935.2025.2487469)
Abstract
15.05 3
24 Vaginal and rectal microbiome changes following administrati… (10.1080/29933935.2024.2334311)
Abstract
11.93 2
25 Contribution of Common Sulfur-Containing Substrates to Hydro… (10.1080/29933935.2024.2361246)
Abstract
11.93 2
26 Preventing chemotherapy-induced diarrhea and microbiota imba… (10.1080/29933935.2024.2379475)
Abstract
11.93 2
27 Gut Microbiota Composition and <i>Clostr… (10.1080/29933935.2024.2390926)
Abstract
11.93 2
28 Site-Specific Gut Microbial Signatures in Non-Celiac Gluten… (10.1080/29933935.2024.2438621)
Abstract
11.93 2
29 Functional regulation of cytotoxic T Cells by gut microbial… (10.1080/29933935.2025.2454002)
Abstract
11.93 2
30 Insights into the gut microbiome-metabolite dynamics in brea… (10.1080/29933935.2025.2483446)
Abstract
11.93 2
31 Landscape of flavonoid metabolism in human gut microbiome an… (10.1080/29933935.2025.2520788)
Abstract
11.93 2
32 The gut microbiota and sleep in infants: a focus on diurnal… (10.1080/29933935.2026.2649096)
Abstract
11.93 2
33 Fecal bile acid profiles before and after fecal microbial tr… (10.1080/29933935.2024.2393219)
Abstract
7.53 1
34 Tracking the origin of bacterial DNA in blood: Indication of… (10.1080/29933935.2025.2482771)
Abstract
7.53 1
35 Alterations in gut microbiota characteristics along a type 2… (10.1080/29933935.2025.2527766)
Abstract
7.53 1
36 Probiotic supplementation improves well-being and anxiety in… (10.1080/29933935.2025.2543125)
Abstract
7.53 1
37 A novel ketogenic diet that reduces seizures and prevents li… (10.1080/29933935.2025.2567677)
Abstract
7.53 1
38 Probiotic strain <i>Bacillus subtilis</i… (10.1080/29933935.2025.2572788)
Abstract
7.53 1
39 Evaluating long-term stool preservation methods for maximizi… (10.1080/29933935.2025.2594958)
Abstract
7.53 1
40 <i>Enterococcus faecalis</i> impairs IGS… (10.1080/29933935.2025.2600896)
Abstract
7.53 1
41 Associations between the infant gut microbiota and the livin… (10.1080/29933935.2025.2603823)
Abstract
7.53 1
42 Using <i>in vitro</i>… (10.1080/29933935.2026.2620183)
Abstract
7.53 1
43 Oleoylethanolamide supplementation enriches Akkermansia muci… (10.1080/29933935.2026.2622259)
Abstract
7.53 1
44 <i>Vpar_1595</i> encodes malate–lactate… (10.1080/29933935.2026.2641986)
Abstract
7.53 1
45 Successful fecal microbiota transplants in post-antibiotic t… (10.1080/29933935.2026.2648346)
Abstract
7.53 1
46 Effect of Shipping on the Microbiome of Donor Mice Used to R… (10.1080/29933935.2024.2363858)
Abstract
0.00 0
47 Microbial Ecology and Metabolism of Emerging Adulthood: Gut… (10.1080/29933935.2024.2387936)
Abstract
0.00 0
48 Fecal Mycobiota in Patients with Inflammatory Bowel Diseases… (10.1080/29933935.2024.2400071)
Abstract
0.00 0
49 Development of a Specialized Method for Simultaneous Quantif… (10.1080/29933935.2024.2429408)
Abstract
0.00 0
50 Characterization of an Indigenous Lytic Phage Targeting Mult… (10.1080/29933935.2025.2452485)
Abstract ORCID
0.00 0